Skip NavigationSkip to Content
Return Return to Search Results

Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge

  1. Author:
    Wilson, N. A.
    Keele, B. F.
    Reed, J. S.
    Piaskowski, S. M.
    MacNair, C. E.
    Bett, A. J.
    Liang, X. P.
    Wang, F. B.
    Thoryk, E.
    Heidecker, G. J.
    Citron, M. P.
    Huang, L. Y.
    Lin, J.
    Vitelli, S.
    Ahn, C. D.
    Kaizu, M.
    Maness, N. J.
    Reynolds, M. R.

  2. Author Address

    Wilson, Nancy A.] Univ Wisconsin, AIDS Vaccine Dev Lab, Dept Pathol & Lab Med, Madison, WI 53711 USA. [Friedrich, Thomas C.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53711 USA. [Keele, Brandon F.; Shaw, George M.; Hahn, Beatrice H.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA. [Keele, Brandon F.; Shaw, George M.; Hahn, Beatrice H.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA. [Erickson, Stephen, Allison, David B.] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA. [Bett, Andrew J.; Liang, Xiaoping, Wang, Fubao, Thoryk, Elizabeth, Heidecker, Gwendolyn J.; Citron, Michael P.; Huang, Lingyi, Lin, Jing, Vitelli, Salvatore, Shiver, John W.; Casimiro, Danilo R.] Merck Res Labs, West Point, PA USA. [Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI Frederick, SAIC Frederick Inc, Frederick, MD USA.
    1. Year: 2009
  2. Journal: Journal of Virology
    1. 83
    2. 13
    3. Pages: 6508-6521
  4. Type of Article: Article
  1. Abstract:

    All human immunodeficiency virus (HIV) vaccine efficacy trials to date have ended in failure. Structural features of the Env glycoprotein and its enormous variability have frustrated efforts to induce broadly reactive neutralizing antibodies. To explore the extent to which vaccine-induced cellular immune responses, in the absence of neutralizing antibodies, can control replication of a heterologous, mucosal viral challenge, we vaccinated eight macaques with a DNA/Ad5 regimen expressing all of the proteins of SIVmac239 except Env. Vaccinees mounted high-frequency T-cell responses against 11 to 34 epitopes. We challenged the vaccinees and eight naive animals with the heterologous biological isolate SIVsmE660, using a regimen intended to mimic typical HIV exposures resulting in infection. Viral loads in the vaccinees were significantly less at both the peak (1.9-log reduction, P < 0.03) and at the set point (2.6-log reduction, P < 0.006) than those in control naive animals. Five of eight vaccinated macaques controlled acute peak viral replication to less than 80,000 viral RNA (vRNA) copy eq/ml and to less than 100 vRNA copy eq/ml in the chronic phase. Our results demonstrate that broad vaccine-induced cellular immune responses can effectively control replication of a pathogenic, heterologous AIDS virus, suggesting that T-cell-based vaccines may have greater potential than previously appreciated.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1128/jvi.00272-09
  3. PMID: 19403685

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel